The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Severe combined immunodeficiencies (SCID)
Open accessAbstract
SCID consists of a group of genetic disorders characterized by a block in T lymphocyte differentiation that is variably associated with abnormal development of other lymphocyte lineages, i.e. B or NK lymphocytes or more rarely of the myeloid lineage [1,2]. At least eight diseases can be distinguished according to phenotype and inheritance pattern (Table 1). The overall frequency is estimated to 1 in 75 000–100 000 births [3,4]. Only those SCIDs with severe T cell depletion will be discussed here, leaving those who usually have normal T cell numbers (e.g. MHC class II and Zap-70 deficiency) for a separate review. Severe combined immunodeficiencies (SCID) Severe combined immunodeficiencies (SCID) The clinical presentation is fairly uniform and is characterized by early onset of infections, mainly of the respiratory tract and gut. We reviewed the frequency of infections and the diagnosis in 117 patients with SCID who were referred to our centre [3]. Oral candidiasis, persistent diarrhoea with growth impairment and/or interstitial pneumonitis are the most frequent infectious manifestations leading to diagnosis. There are no differences between the various SCIDs, except for an earlier onset of infections in patients with ADA deficiency. The persistence and recurrence of infections in SCID patients rapidly lead to growth impairment and malnutrition. Our findings were similar to an American study of 100 infants [4]. Even common opportunistic organisms such as Pneumocystis carinii and Aspergillus species can cause infections. Intracellular organisms such as listeria and legionella can cause devastating disease, as can viruses, especially those of the herpes group. Infection by Epstein–Barr virus (EBV), although rare in this age group, can lead to uncontrolled B lymphocyte proliferative disorders (BLPD) in B(+) SCID patients, similar to that seen in immunosuppressed transplant recipients. Thirty-one such cases have been reported [5]. Some occurred following therapy of SCID (thymic transplant, fetal liver transplant or T-depleted marrow transplant), which was presumably the source of EBV. BLPD has also developed in untreated SCID patients [6]. Live vaccines can also cause life-threatening infections. We have observed BCG infection in 10/28 vaccinated patients (including two with local infection and eight with disseminated involvement of the liver, spleen and lungs), which was fatal in three cases [3]. Interestingly, three of six patients who received oral attenuated poliovirus had detectable virus in the stools, but none developed poliomyelitis; this was probably either because of slow viral replication in transplant recipients or because of protection by maternal immunoglobulins. It is clear that live vaccine must not be given to children at risk for SCID. Non-infectious clinical manifestations consist mainly of graft-versus-host disease (GVHD) caused by the patients' inability to reject allogeneic cells. The two possible sources of allogeneic cells are maternal lymphocytes and transfusion. Maternal T lymphocyte engraftment is frequently detected in SCID patients using molecular tools [7,8]. Circulating maternal T cells are detected in approximately 50% of cases. It is noteworthy that maternal T cells are not found in ADA-deficient patients, possibly because maternal T cells are killed by the raised levels of deoxyadenosine (see below). Maternal T lymphocyte numbers range from 10 to several thousand/μl of blood. They usually have a normal phenotype, with some degree of in vivo activation, as shown by the expression of MHC class II molecules and/or the IL-2 receptor [9]. In some cases, maternal T cells have been reported to be clonal [5,9], a finding suggestive of either transplacental passage of a very small number of T cells or secondary expansion of alloreactive clones in the host. The most intriguing observation regarding maternal T cell engraftment in SCID patients is the paucity of clinical manifestations. In the majority of cases, the presence of maternal T cells is entirely asymptomatic, while approximately 30–40% of patients have mild symptoms and signs such as erythema with skin T cell infiltration, eosinophilia, and elevated liver enzymes with periportal T cell infiltration [3]. In recent years there have been no reports of fatal GVHD caused by maternal T cell engraftment in SCID patients. Several explanations have been proposed: they include oligoclonality of maternal T cells with lack of alloreactivity toward the child's antigens, or tolerance of transfused maternal T cells because of associated mild haematopoietic stem cell engraftment (and T cell differentiation). The presence of a few maternal T cells in the periphery should not delay or confuse the diagnosis of SCID. It may be an obstacle to T cell engraftment following T-depleted haplo-identical bone marrow transplantation (BMT), especially if the donor is not the mother and if the patient is not treated with myeloablative and immunosuppressive drug
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
Kondo, M., Weissman, I. L., & Akashi, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80453-5 · Cited by 2,253
IMMUNOLOGICAL RECONSTITUTION OF SEX-LINKED LYMPHOPENIC IMMUNOLOGICAL DEFICIENCY
Gatti, R., Meuwissen, H., Allen, H., Hong, R., & Good, R. (1968) · The Lancet · doi:10.1016/s0140-6736(68)92673-1 · Cited by 1,018
Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency
Puel, A., Ziegler, S. F., Buckley, R. H., & Leonard., W. J. (1998) · Nature Genetics · doi:10.1038/3877 · Cited by 813
Cited by
T cell receptor (TCR) signaling in health and disease
Shah, K., Al-Haidari, A., Sun, J., & Kazi, J. U. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00823-w · Cited by 604
Direct estimates of human per nucleotide mutation rates at 20 loci causing mendelian diseases
Kondrashov, A. S. (2003) · Human Mutation · doi:10.1002/humu.10147 · Cited by 336
Lentiviral Vectors for the Treatment and Prevention of Cystic Fibrosis Lung Disease
Marquez Loza, L. I., Yuen, E. C., & McCray, P. B. (2019) · Genes · doi:10.3390/genes10030218 · Cited by 59
Metadata
- Authors
- Fischer, A.
- Venue
- Clinical and Experimental Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-11
- Volume
- 122
- Issue
- 2
- Pages
- 143-149
- ISSN
- 0009-9104 (ISSN-L)
- 1365-2249
- OpenAlex
- W2035151180
- Cited by
- 170
- References
- 3
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Severe combined immunodeficiencies (SCID). https://app.cochat.ai/papers/10.1046/j.1365-2249.2000.01359.x
- The paper
- Fischer, A. (2008). Severe combined immunodeficiencies (SCID). Clinical and Experimental Immunology. https://doi.org/10.1046/j.1365-2249.2000.01359.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.